Canopy Rivers Stock Forecast, Price & News

+0.19 (+8.12 %)
(As of 09/6/2019)
Today's Range
50-Day Range
52-Week Range
Volume984,044 shs
Average Volume485,227 shs
Market CapitalizationC$474.50 million
P/E Ratio72.29
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive RIV News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Rivers and its competitors with MarketBeat's FREE daily newsletter.

Canopy Rivers logo

About Canopy Rivers

Canopy Rivers Inc. is a public investment firm. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies. It seeks to make minority stakes. The company is headquartered in Toronto, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Canopy Rivers (CVE:RIV) Frequently Asked Questions

What stocks does MarketBeat like better than Canopy Rivers?

Wall Street analysts have given Canopy Rivers a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Canopy Rivers wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for RIV?

0 equities research analysts have issued 12 month target prices for Canopy Rivers' stock. Their forecasts range from C$2.50 to C$2.50. On average, they expect Canopy Rivers' stock price to reach C$2.50 in the next year. This suggests that the stock has a possible downside of 1.2%.
View analysts' price targets for Canopy Rivers
or view top-rated stocks among Wall Street analysts.

Who are Canopy Rivers' key executives?

Canopy Rivers' management team includes the following people:
  • Mr. Bruce A. Linton, CEO & Chairman (Age 52)
  • Mr. Narbe Alexandrian C.A., CPA, CPA, Pres
  • Mr. Peter Hatziioannou, Co-Founder & Advisor
  • Mr. Sean McNulty, Co-Founder & Advisor
  • Mr. Edward James Cirillo Lucarelli, Chief Financial Officer (Age 32)

Who are some of Canopy Rivers' key competitors?

What other stocks do shareholders of Canopy Rivers own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Rivers investors own include (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), OrganiGram (OGI), Aurora Cannabis (ACB), Aphria (APHA), The Green Organic Dutchman (TGOD), Curaleaf (CURLF), Matica Enterprises (MMJ) and Cronos Group (CRON).

What is Canopy Rivers' stock symbol?

Canopy Rivers trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RIV."

How do I buy shares of Canopy Rivers?

Shares of RIV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Canopy Rivers' stock price today?

One share of RIV stock can currently be purchased for approximately C$2.53.

How much money does Canopy Rivers make?

Canopy Rivers has a market capitalization of C$474.50 million and generates C$40.42 million in revenue each year.

What is Canopy Rivers' official website?

The official website for Canopy Rivers is

How can I contact Canopy Rivers?

The venture capital firm can be reached via phone at 855-227-8639 or via email at [email protected].

This page was last updated on 9/19/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.